Oragenics (OGEN) Competitors $0.19 0.00 (-2.21%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.19 0.00 (-1.05%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock OGEN vs. UPXI, MBRX, NRSN, INAB, FLGC, BCDA, GOVX, EQ, EDSA, and LPTXShould you be buying Oragenics stock or one of its competitors? The main competitors of Oragenics include Upexi (UPXI), Moleculin Biotech (MBRX), NeuroSense Therapeutics (NRSN), IN8bio (INAB), Flora Growth (FLGC), BioCardia (BCDA), GeoVax Labs (GOVX), Equillium (EQ), Edesa Biotech (EDSA), and Leap Therapeutics (LPTX). These companies are all part of the "pharmaceutical products" industry. Oragenics vs. Upexi Moleculin Biotech NeuroSense Therapeutics IN8bio Flora Growth BioCardia GeoVax Labs Equillium Edesa Biotech Leap Therapeutics Upexi (NASDAQ:UPXI) and Oragenics (NYSE:OGEN) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation. Do institutionals and insiders believe in UPXI or OGEN? 5.7% of Upexi shares are owned by institutional investors. Comparatively, 18.7% of Oragenics shares are owned by institutional investors. 31.6% of Upexi shares are owned by insiders. Comparatively, 4.9% of Oragenics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is UPXI or OGEN more profitable? Upexi's return on equity of 0.00% beat Oragenics' return on equity.Company Net Margins Return on Equity Return on Assets UpexiN/A N/A N/A Oragenics N/A -2,087.95%-486.56% Does the media favor UPXI or OGEN? In the previous week, Upexi and Upexi both had 1 articles in the media. Upexi's average media sentiment score of 0.00 equaled Oragenics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Upexi 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Oragenics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation and earnings, UPXI or OGEN? Oragenics has lower revenue, but higher earnings than Upexi. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpexi$16.56M0.92-$23.66MN/AN/AOragenics$40K102.01-$20.66M-$1.12-0.17 Does the MarketBeat Community prefer UPXI or OGEN? Upexi received 3 more outperform votes than Oragenics when rated by MarketBeat users. Likewise, 42.86% of users gave Upexi an outperform vote while only 0.00% of users gave Oragenics an outperform vote. CompanyUnderperformOutperformUpexiOutperform Votes342.86% Underperform Votes457.14% OragenicsOutperform VotesNo VotesUnderperform Votes55100.00% Which has more risk and volatility, UPXI or OGEN? Upexi has a beta of -0.27, meaning that its share price is 127% less volatile than the S&P 500. Comparatively, Oragenics has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. SummaryUpexi beats Oragenics on 6 of the 10 factors compared between the two stocks. Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGEN vs. The Competition Export to ExcelMetricOragenicsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$4.08M$6.46B$5.34B$19.26BDividend YieldN/A2.63%5.27%3.86%P/E Ratio-0.038.4426.9634.42Price / Sales102.01258.50398.8334.89Price / CashN/A65.8538.3217.51Price / Book0.316.416.774.69Net Income-$20.66M$143.95M$3.24B$1.02B7 Day Performance-5.00%0.24%0.27%-2.38%1 Month Performance-3.55%0.37%5.91%4.18%1 Year Performance-91.44%0.56%18.83%4.87% Oragenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGENOragenicsN/A$0.19-2.2%N/A-91.5%$4.08M$40,000.00-0.035UPXIUpexi0.345 of 5 stars$10.64+7.4%N/A+6.8%$15.17M$18.63M0.00130News CoverageEarnings ReportGap DownHigh Trading VolumeMBRXMoleculin Biotech2.1719 of 5 stars$1.08+2.9%$6.00+455.6%-80.7%$15.12MN/A0.0020Positive NewsNRSNNeuroSense Therapeutics1.9881 of 5 stars$1.10+5.4%N/A+30.2%$15.03MN/A-1.7210Gap UpINABIN8bio2.9795 of 5 stars$0.16+3.6%$6.00+3,581.0%-85.7%$14.80MN/A-0.2220FLGCFlora Growth2.4988 of 5 stars$0.75+10.5%$5.00+566.7%-46.0%$14.58M$59.51M-0.57280BCDABioCardia2.7666 of 5 stars$2.84-0.4%$25.00+780.3%-62.0%$14.47M$58,000.00-0.6840GOVXGeoVax Labs2.7821 of 5 stars$0.93-0.3%$11.10+1,099.9%-42.0%$14.06M$5.59M-0.2510Positive NewsEQEquillium2.6683 of 5 stars$0.39-0.1%$3.00+669.2%-71.0%$13.93M$41.10M-2.7940Gap DownEDSAEdesa Biotech2.5858 of 5 stars$1.98-3.4%$21.00+960.6%-54.9%$13.91MN/A-1.0620News CoverageAnalyst RevisionLPTXLeap Therapeutics2.3919 of 5 stars$0.38+12.0%$4.92+1,210.8%-84.7%$13.88MN/A-0.1940Gap Down Related Companies and Tools Related Companies Upexi Competitors Moleculin Biotech Competitors NeuroSense Therapeutics Competitors IN8bio Competitors Flora Growth Competitors BioCardia Competitors GeoVax Labs Competitors Equillium Competitors Edesa Biotech Competitors Leap Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OGEN) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
